0 XP   0   0   0

Fermenta Biotech Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Fermenta Biotech Ltd?

I guess you are interested in Fermenta Biotech Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Fermenta Biotech Ltd

Let's start. I'm going to help you getting a better view of Fermenta Biotech Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Fermenta Biotech Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Fermenta Biotech Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Fermenta Biotech Ltd. The closing price on 2023-01-27 was INR169.55 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Fermenta Biotech Ltd Daily Candlestick Chart
Fermenta Biotech Ltd Daily Candlestick Chart
Summary









1. Valuation of Fermenta Biotech Ltd




Current price per share

INR169.55

2. Growth of Fermenta Biotech Ltd




Is Fermenta Biotech Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$45.7m$44.3m$1.4m3.1%

How much money is Fermenta Biotech Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.8m$5.5m-$3.6m-194.6%
Net Profit Margin3.9%12.1%--

How much money comes from the company's main activities?

3. Financial Health of Fermenta Biotech Ltd




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Fermenta Biotech Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fermenta Biotech Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Fermenta Biotech Ltd to the  industry mean.
  • A Net Profit Margin of 3.9% means that ₹0.04 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fermenta Biotech Ltd:

  • The MRQ is 3.9%. The company is making a profit. +1
  • The TTM is 3.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.9%0.0%
TTM3.9%YOY12.1%-8.2%
TTM3.9%5Y15.3%-11.4%
5Y15.3%10Y11.6%+3.7%
1.1.2. Return on Assets

Shows how efficient Fermenta Biotech Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fermenta Biotech Ltd to the  industry mean.
  • 2.2% Return on Assets means that Fermenta Biotech Ltd generated ₹0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fermenta Biotech Ltd:

  • The MRQ is 2.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.2%TTM2.2%0.0%
TTM2.2%YOY6.6%-4.4%
TTM2.2%5Y9.7%-7.5%
5Y9.7%10Y7.5%+2.2%
1.1.3. Return on Equity

Shows how efficient Fermenta Biotech Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fermenta Biotech Ltd to the  industry mean.
  • 4.2% Return on Equity means Fermenta Biotech Ltd generated ₹0.04 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fermenta Biotech Ltd:

  • The MRQ is 4.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.2%TTM4.2%0.0%
TTM4.2%YOY12.6%-8.5%
TTM4.2%5Y22.0%-17.8%
5Y22.0%10Y17.0%+5.0%

1.2. Operating Efficiency of Fermenta Biotech Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fermenta Biotech Ltd is operating .

  • Measures how much profit Fermenta Biotech Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fermenta Biotech Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fermenta Biotech Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Fermenta Biotech Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.46 means that the operating costs are ₹0.46 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Fermenta Biotech Ltd:

  • The MRQ is 0.465. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.465. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.465TTM0.4650.000
TTM0.465YOY0.417+0.048
TTM0.4655Y0.369+0.096
5Y0.36910Y0.378-0.009

1.3. Liquidity of Fermenta Biotech Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fermenta Biotech Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.52 means the company has ₹1.52 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Fermenta Biotech Ltd:

  • The MRQ is 1.516. The company is able to pay all its short-term debts. +1
  • The TTM is 1.516. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.516TTM1.5160.000
TTM1.516YOY1.479+0.037
TTM1.5165Y1.622-0.106
5Y1.62210Y1.553+0.069
1.3.2. Quick Ratio

Measures if Fermenta Biotech Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fermenta Biotech Ltd to the  industry mean.
  • A Quick Ratio of 0.68 means the company can pay off ₹0.68 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fermenta Biotech Ltd:

  • The MRQ is 0.680. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.680. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.680TTM0.6800.000
TTM0.680YOY0.669+0.011
TTM0.6805Y0.873-0.193
5Y0.87310Y0.837+0.036

1.4. Solvency of Fermenta Biotech Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fermenta Biotech Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fermenta Biotech Ltd to industry mean.
  • A Debt to Asset Ratio of 0.47 means that Fermenta Biotech Ltd assets are financed with 47.4% credit (debt) and the remaining percentage (100% - 47.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fermenta Biotech Ltd:

  • The MRQ is 0.474. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.474. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.474TTM0.4740.000
TTM0.474YOY0.475-0.002
TTM0.4745Y0.533-0.060
5Y0.53310Y0.533+0.000
1.4.2. Debt to Equity Ratio

Measures if Fermenta Biotech Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fermenta Biotech Ltd to the  industry mean.
  • A Debt to Equity ratio of 89.9% means that company has ₹0.90 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fermenta Biotech Ltd:

  • The MRQ is 0.899. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.899. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.899TTM0.8990.000
TTM0.899YOY0.905-0.006
TTM0.8995Y1.216-0.316
5Y1.21610Y1.202+0.014

2. Market Valuation of Fermenta Biotech Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Fermenta Biotech Ltd generates.

  • Above 15 is considered overpriced but always compare Fermenta Biotech Ltd to the  industry mean.
  • A PE ratio of 54.19 means the investor is paying ₹54.19 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fermenta Biotech Ltd:

  • The EOD is 31.663. Good. +1
  • The MRQ is 54.185. Good. +1
  • The TTM is 54.185. Good. +1
Trends
Current periodCompared to+/- 
EOD31.663MRQ54.185-22.522
MRQ54.185TTM54.1850.000
TTM54.185YOY20.127+34.058
TTM54.1855Y21.130+33.056
5Y21.13010Y15.149+5.981
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Fermenta Biotech Ltd.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Fermenta Biotech Ltd:

  • The MRQ is 159.628. Seems overpriced? -1
  • The TTM is 159.628. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ159.628TTM159.6280.000
TTM159.628YOY26.327+133.300
TTM159.6285Y42.923+116.705
5Y42.92310Y42.9230.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fermenta Biotech Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 2.25 means the investor is paying ₹2.25 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Fermenta Biotech Ltd:

  • The EOD is 1.314. Good. +1
  • The MRQ is 2.249. Good. +1
  • The TTM is 2.249. Good. +1
Trends
Current periodCompared to+/- 
EOD1.314MRQ2.249-0.935
MRQ2.249TTM2.2490.000
TTM2.249YOY2.540-0.291
TTM2.2495Y2.786-0.537
5Y2.78610Y2.516+0.270
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Fermenta Biotech Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.0024.0020%17.733-77%15.306-74%21.500-81%
Book Value Growth--1.0321.0320%1.165-11%1.261-18%1.261-18%
Book Value Per Share--129.001129.0010%125.000+3%99.507+30%91.668+41%
Book Value Per Share Growth--1.0321.0320%1.165-11%1.250-17%1.250-17%
Current Ratio--1.5161.5160%1.479+3%1.622-7%1.553-2%
Debt To Asset Ratio--0.4740.4740%0.4750%0.533-11%0.533-11%
Debt To Equity Ratio--0.8990.8990%0.905-1%1.216-26%1.202-25%
Dividend Per Share--2.5002.5000%-+100%1.072+133%0.936+167%
Eps--5.3555.3550%15.775-66%19.339-72%15.424-65%
Eps Growth--0.3390.3390%0.764-56%2.004-83%2.004-83%
Free Cash Flow Per Share--2.1882.1880%2.752-20%5.484-60%3.533-38%
Free Cash Flow Per Share Growth--0.7950.7950%2.233-64%1.626-51%1.626-51%
Free Cash Flow To Equity Per Share---5.292-5.2920%2.355-325%7.962-166%4.865-209%
Free Cash Flow To Equity Per Share Growth---2.247-2.2470%2.083-208%1.118-301%1.118-301%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---73.921--------
Intrinsic Value_10Y_min---60.217--------
Intrinsic Value_1Y_max--0.120--------
Intrinsic Value_1Y_min--0.117--------
Intrinsic Value_3Y_max---5.376--------
Intrinsic Value_3Y_min---4.975--------
Intrinsic Value_5Y_max---17.789--------
Intrinsic Value_5Y_min---15.864--------
Net Profit Margin--0.0390.0390%0.121-68%0.153-75%0.116-67%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.4650.4650%0.417+11%0.369+26%0.378+23%
Pb Ratio1.314-71%2.2492.2490%2.540-11%2.786-19%2.516-11%
Pe Ratio31.663-71%54.18554.1850%20.127+169%21.130+156%15.149+258%
Peg Ratio--159.628159.6280%26.327+506%42.923+272%42.923+272%
Price Per Share169.550-71%290.150290.1500%317.500-9%265.870+9%231.767+25%
Price To Total Gains Ratio26.077-71%44.62544.6250%17.905+149%12.433+259%10.554+323%
Profit Growth--0.3390.3390%0.764-56%2.009-83%2.009-83%
Quick Ratio--0.6800.6800%0.669+2%0.873-22%0.837-19%
Return On Assets--0.0220.0220%0.066-67%0.097-78%0.075-71%
Return On Equity--0.0420.0420%0.126-67%0.220-81%0.170-76%
Revenue Growth--1.0561.0560%1.288-18%1.246-15%1.246-15%
Total Gains Per Share--6.5026.5020%17.733-63%16.377-60%22.437-71%
Total Gains Per Share Growth--0.3670.3670%0.970-62%2.046-82%2.046-82%
Usd Book Value--45772568.10045772568.1000%44352594.600+3%34862044.980+31%32011885.700+43%
Usd Book Value Change Per Share--0.0490.0490%0.218-77%0.188-74%0.264-81%
Usd Book Value Per Share--1.5871.5870%1.537+3%1.224+30%1.128+41%
Usd Dividend Per Share--0.0310.0310%-+100%0.013+133%0.012+167%
Usd Eps--0.0660.0660%0.194-66%0.238-72%0.190-65%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share--0.0270.0270%0.034-20%0.067-60%0.043-38%
Usd Free Cash Flow To Equity Per Share---0.065-0.0650%0.029-325%0.098-166%0.060-209%
Usd Price Per Share2.085-71%3.5693.5690%3.905-9%3.270+9%2.851+25%
Usd Profit--1899993.3001899993.3000%5597311.800-66%6682521.120-72%5334571.500-64%
Usd Revenue--49017431.10049017431.1000%46406522.400+6%43699437.540+12%39812808.100+23%
Usd Total Gains Per Share--0.0800.0800%0.218-63%0.201-60%0.276-71%
 EOD+3 -2MRQTTM+0 -0YOY+13 -265Y+11 -2810Y+11 -28

3.2. Fundamental Score

Let's check the fundamental score of Fermenta Biotech Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.663
Price to Book Ratio (EOD)Between0-11.314
Net Profit Margin (MRQ)Greater than00.039
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.680
Current Ratio (MRQ)Greater than11.516
Debt to Asset Ratio (MRQ)Less than10.474
Debt to Equity Ratio (MRQ)Less than10.899
Return on Equity (MRQ)Greater than0.150.042
Return on Assets (MRQ)Greater than0.050.022
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Fermenta Biotech Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose175.400
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets7,068,425
Total Liabilities3,347,078
Total Stockholder Equity3,721,347
 As reported
Total Liabilities 3,347,078
Total Stockholder Equity+ 3,721,347
Total Assets = 7,068,425

Assets

Total Assets7,068,425
Total Current Assets3,140,199
Long-term Assets3,140,199
Total Current Assets
Cash And Cash Equivalents 119,221
Short-term Investments 203,988
Net Receivables 870,901
Inventory 1,594,765
Other Current Assets 311,980
Total Current Assets  (as reported)3,140,199
Total Current Assets  (calculated)3,100,855
+/- 39,344
Long-term Assets
Property Plant Equipment 2,373,269
Goodwill 109,545
Intangible Assets 175,952
Long-term Assets  (as reported)0
Long-term Assets  (calculated)2,658,766
+/- 2,658,766

Liabilities & Shareholders' Equity

Total Current Liabilities2,071,234
Long-term Liabilities-
Total Stockholder Equity3,721,347
Total Current Liabilities
Short-term Debt 974,750
Total Current Liabilities  (as reported)2,071,234
Total Current Liabilities  (calculated)974,750
+/- 1,096,484
Long-term Liabilities
Long term Debt Total 1,166,503
Capital Lease Obligations Min Short Term Debt-974,750
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)191,753
+/- 191,753
Total Stockholder Equity
Common Stock144,237
Retained Earnings 3,422,582
Capital Surplus 146,916
Other Stockholders Equity 7,612
Total Stockholder Equity (as reported)3,721,347
Total Stockholder Equity (calculated)3,721,347
+/-0
Other
Cash And Equivalents11,340
Cash and Short Term Investments 334,549
Common Stock Shares Outstanding 28,847
Liabilities and Stockholders Equity 7,068,425



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
3,078,256
3,846,420
5,512,471
6,136,745
6,870,762
7,068,425
7,068,4256,870,7626,136,7455,512,4713,846,4203,078,256
   > Total Current Assets 
1,042,571
1,822,651
2,956,091
2,840,131
3,096,215
3,140,199
3,140,1993,096,2152,840,1312,956,0911,822,6511,042,571
       Cash And Cash Equivalents 
0
0
117,744
75,145
135,029
119,221
119,221135,02975,145117,74400
       Short-term Investments 
46,506
19,611
513,646
254,233
276,312
203,988
203,988276,312254,233513,64619,61146,506
       Net Receivables 
445,710
687,193
655,440
697,742
680,148
870,901
870,901680,148697,742655,440687,193445,710
       Inventory 
389,138
511,788
876,653
1,285,819
1,622,705
1,594,765
1,594,7651,622,7051,285,819876,653511,788389,138
       Other Current Assets 
134,818
276,525
365,252
296,178
279,774
311,980
311,980279,774296,178365,252276,525134,818
   > Long-term Assets 000000
       Property Plant Equipment 
884,117
931,379
1,180,248
1,853,632
2,194,116
2,373,269
2,373,2692,194,1161,853,6321,180,248931,379884,117
       Goodwill 
41,333
41,279
41,279
41,279
107,135
109,545
109,545107,13541,27941,27941,27941,333
       Intangible Assets 
27,531
31,054
31,619
101,694
210,090
175,952
175,952210,090101,69431,61931,05427,531
> Total Liabilities 
1,634,265
2,601,938
3,006,993
3,042,391
3,264,860
3,347,078
3,347,0783,264,8603,042,3913,006,9932,601,9381,634,265
   > Total Current Liabilities 
861,588
1,035,555
1,559,765
1,945,973
2,093,335
2,071,234
2,071,2342,093,3351,945,9731,559,7651,035,555861,588
       Short-term Debt 
371,302
298,551
602,125
1,043,330
962,995
974,750
974,750962,9951,043,330602,125298,551371,302
   > Long-term Liabilities 000000
       Long term Debt Total 
403,196
1,353,679
1,352,093
1,044,274
1,121,382
1,166,503
1,166,5031,121,3821,044,2741,352,0931,353,679403,196
> Total Stockholder Equity
1,443,991
1,244,482
2,505,478
3,094,354
3,605,902
3,721,347
3,721,3473,605,9023,094,3542,505,4781,244,4821,443,991
   Common Stock
22,932
22,932
45,864
144,237
144,237
144,237
144,237144,237144,23745,86422,93222,932
   Retained Earnings 
1,421,059
1,221,550
2,450,936
2,887,884
3,342,589
3,422,582
3,422,5823,342,5892,887,8842,450,9361,221,5501,421,059
   Capital Surplus 
0
0
7,495
60,749
119,954
146,916
146,916119,95460,7497,49500
   Treasury Stock000000
   Other Stockholders Equity 
0
0
1,183
1,484
-878
7,612
7,612-8781,4841,18300



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue3,985,157
Cost of Revenue-1,852,122
Gross Profit2,133,0352,133,035
 
Operating Income (+$)
Gross Profit2,133,035
Operating Expense--
Operating Income359,1822,133,035
 
Operating Expense (+$)
Research Development-
Selling General Administrative976,076
Selling And Marketing Expenses-
Operating Expense-976,076
 
Net Interest Income (+$)
Interest Income135,283
Interest Expense-28,364
Net Interest Income-106,919
 
Pretax Income (+$)
Operating Income359,182
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)269,431359,182
EBIT - interestExpense = -28,364
154,471
182,835
Interest Expense28,364
Earnings Before Interest and Taxes (ebit)-297,795
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax269,431
Tax Provision-118,825
Net Income From Continuing Ops-150,606
Net Income154,471
Net Income Applicable To Common Shares154,471
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
3 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
3 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
3 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
3 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart